A novel class of broad-spectrum active-site-directed 3C-like protease inhibitors with nanomolar antiviral activity against highly immune-evasive SARS-CoV-2 Omicron subvariants
一类新型广谱活性位点定向 3C 样蛋白酶抑制剂,具有纳摩尔级抗病毒活性,可对抗高度免疫逃避型 SARS-CoV-2 Omicron 亚变体
期刊:Emerging Microbes & Infections
影响因子:8.4
doi:10.1080/22221751.2023.2246594
Jimena Pérez-Vargas, Liam J Worrall, Andrea D Olmstead, Anh-Tien Ton, Jaeyong Lee, Ivan Villanueva, Connor A H Thompson, Svenja Dudek, Siobhan Ennis, Jason R Smith, Tirosh Shapira, Joshua De Guzman, Shutong Gang, Fuqiang Ban, Marija Vuckovic, Michael Bielecki, Suzana Kovacic, Calem Kenward, Christop